Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.725 USD | +0.09% | -6.00% | +31.78% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 61.44M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.81
x | P/E ratio 2025 * |
-3.04
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.94% |
Latest transcript on Lantern Pharma Inc.
1 day | +7.12% | ||
1 week | -4.19% | ||
Current month | -35.00% | ||
1 month | -46.29% | ||
3 months | +38.16% | ||
6 months | +108.76% | ||
Current year | +33.64% |
Managers | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
David Margrave
DFI | Director of Finance/CFO | 64 | 18-05-31 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
Director/Board Member | 73 | 22-06-07 | |
Donald Keyser
CHM | Chairman | 71 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 5.675 | -0.79% | 3 148 |
24-04-22 | 5.72 | +7.12% | 255,410 |
24-04-19 | 5.34 | -7.45% | 237,791 |
24-04-18 | 5.77 | -3.67% | 107,146 |
24-04-17 | 5.99 | -0.17% | 161,871 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.64% | 61.44M | |
-0.02% | 42.11B | |
+49.00% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- LTRN Stock